Prokidney (PROK) Revenue (2024 - 2026)

Prokidney's (PROK) quarterly Revenue came in at $226000.0 in Q1 2026, down 1.74% year-on-year from $230000.0 in Q1 2025, and little changed on a QoQ basis from $225000.0 in Q4 2025.

Prokidney (PROK) Revenue (2024 - 2026) Analysis & Trends

Prokidney (PROK) has 3 years of Revenue data on file, last reported at $226000.0 in Q1 2026.

  • On a quarterly basis, Revenue fell 1.74% year-over-year to $226000.0 in Q1 2026; TTM through Mar 2026 was $889000.0, a 190.52% increase from a year earlier, with the FY2025 full-year figure at $893000.0, up 1075.0% from the prior year.
  • Revenue for Q1 2026 stood at $226000.0, roughly flat from $225000.0 in the prior quarter.
  • Over the last five years, Revenue for PROK reached as high as $230000.0 in Q1 2025 and fell as low as $76000.0 in Q4 2024.
  • Historically, Revenue has averaged $199166.7 across 3 years, with a median of $223000.0 in 2025.
  • Across the five-year window, Revenue soared 196.05% in 2025 and declined 1.74% in 2026, its largest moves.
  • Year by year, Revenue stood at $76000.0 in 2024, then jumped by 196.05% to $225000.0 in 2025, then rose by 0.44% to $226000.0 in 2026.
  • Per Business Quant data, the three most recent Revenue figures were $226000.0 in Q1 2026, $225000.0 in Q4 2025, and $217000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.56 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Prokidney 96.00 Mn 96.00 Mn - 226,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 226,000.00
Dec 31, 2025 225,000.00
Sep 30, 2025 217,000.00
Jun 30, 2025 221,000.00
Mar 31, 2025 230,000.00
Dec 31, 2024 76,000.00